You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

PROLIXIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prolixin, and when can generic versions of Prolixin launch?

Prolixin is a drug marketed by Apothecon and Bristol Myers Squibb and is included in five NDAs.

The generic ingredient in PROLIXIN is fluphenazine enanthate. There are nineteen drug master file entries for this compound. Additional details are available on the fluphenazine enanthate profile page.

Drug patent expirations by year for PROLIXIN
Recent Clinical Trials for PROLIXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Canadian Institutes of Health Research (CIHR)Phase 2
Centre for Addiction and Mental HealthPhase 2

See all PROLIXIN clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for PROLIXIN

US Patents and Regulatory Information for PROLIXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apothecon PROLIXIN fluphenazine hydrochloride CONCENTRATE;ORAL 070533-001 Nov 7, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-002 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon PROLIXIN fluphenazine hydrochloride TABLET;ORAL 011751-004 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Bristol Myers Squibb PROLIXIN DECANOATE fluphenazine decanoate INJECTABLE;INJECTION 016727-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon PROLIXIN fluphenazine hydrochloride ELIXIR;ORAL 012145-003 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apothecon PROLIXIN fluphenazine hydrochloride INJECTABLE;INJECTION 011751-005 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.